UBE2J1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.457550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.276040E-01
Normal-vs-Stage2
1.532250E-02
Normal-vs-Stage3
1.128610E-01
Normal-vs-Stage4
3.956200E-01
Stage1-vs-Stage2
8.451000E-01
Stage1-vs-Stage3
7.745200E-01
Stage1-vs-Stage4
3.260000E-01
Stage2-vs-Stage3
6.218200E-01
Stage2-vs-Stage4
2.684200E-01
Stage3-vs-Stage4
1.540780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.214330E-02
Normal-vs-AfricanAmerican
4.782200E-01
Normal-vs-Asian
2.426000E-02
Caucasian-vs-AfricanAmerican
9.888000E-02
Caucasian-vs-Asian
2.632400E-01
AfricanAmerican-vs-Asian
7.966100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.357700E-03
Normal-vs-Female
4.040100E-02
Male-vs-Female
8.162200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.571630E-01
Normal-vs-Age(41-60Yrs)
3.907800E-02
Normal-vs-Age(61-80Yrs)
1.593700E-02
Normal-vs-Age(81-100Yrs)
2.391500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.250600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.399600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.633400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.053780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.415200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.877400E-03
Normal-vs-Daily Drinker
1.903970E-01
Normal-vs-Weekly Drinker
2.974300E-02
Normal-vs-Occasional Drinker
1.175820E-01
Normal-vs-Social Drinker
7.113900E-02
Non Drinker-vs-Daily Drinker
3.269200E-01
Non Drinker-vs-Weekly Drinker
5.910000E-01
Non Drinker-vs-Occasional Drinker
1.805040E-01
Non Drinker-vs-Social Drinker
1.482410E-01
Daily Drinker-vs-Weekly Drinker
1.571550E-01
Daily Drinker-vs-Occasional Drinker
5.508400E-02
Daily Drinker-vs-Social Drinker
2.143800E-02
Weekly Drinker-vs-Occasional Drinker
4.981200E-01
Weekly Drinker-vs-Social Drinker
4.277200E-01
Occasional Drinker-vs-Social Drinker
9.864200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.338200E-01
Normal-vs-Grade 2
8.867200E-01
Normal-vs-Grade 3
9.336800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.612000E-01
Grade 1-vs-Grade 3
2.958600E-01
Grade 1-vs-Grade 4
6.338200E-01
Grade 2-vs-Grade 3
4.063000E-01
Grade 2-vs-Grade 4
8.867200E-01
Grade 3-vs-Grade 4
9.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.809600E-02
Normal-vs-NonDiabetic
2.484000E-01
Diabetic-vs-NonDiabetic
5.419600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.705630E-01
Normal-vs-NoPancreatitis
8.721700E-03
Pancreatitis-vs-NoPancreatitis
3.458400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.946100E-02
Normal-vs-N1
1.004000E-02
N0-vs-N1
9.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.064600E-01
Normal-vs-TP53-NonMutant
9.813900E-02
TP53-Mutant-vs-TP53-NonMutant
3.100100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
